Across OECD countries, for every 10% reduction in CVD mortality, life expectancy at age 65 increased by around 4.3%. The decline in CVD mortality accounts for around 30% of the cross-country variation in life expectancy gains. Change in CVD mortality is a stronger predictor of life expectancy at 65 among males than females.